Malta - Kiingereza - Medicines Authority

astellas pharma europe b.v. - tamsulosin hydrochloride - modified-release capsule - tamsulosin hydrochloride 0.4 milligram(s) - urologicals

Malta - Kiingereza - Medicines Authority

astellas pharma europe b.v. - tamsulosin hydrochloride - film-coated tablet - tamsulosin hydrochloride 0.4 milligram(s) - urologicals

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - somatropin 6.67 mg/ml - solution for injection - 10 mg/1.5ml - active: somatropin 6.67 mg/ml excipient: dibasic sodium phosphate glycine monobasic sodium phosphate phenol phosphoric acid poloxamer 188 sodium hydroxide water for injection - adults replacement therapy in adults with pronounced growth hormone deficiency as diagnosed in two different dynamic tests for growth hormone deficiency. patients must also fulfill the following criteria. childhood onset: patients, who were diagnosed as growth hormone deficient during childhood, must be retested and their growth hormone deficiency confirmed before replacement therapy is started. adult onset: patients must have growth hormone deficiency as a result of hypothalamic or pituitary disease and at least one other hormone deficiency diagnosed (except for prolactin) and adequate replacement therapy instituted, before replacement therapy using growth hormone may begin. prader-willi syndrome, for improvement of body composition.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - somatropin 10 mg/ml - solution for injection - 15 mg/1.5ml - active: somatropin 10 mg/ml excipient: dibasic sodium phosphate monobasic sodium phosphate phenol phosphoric acid poloxamer 188 sodium chloride sodium hydroxide water for injection - adults replacement therapy in adults with pronounced growth hormone deficiency as diagnosed in two different dynamic tests for growth hormone deficiency. patients must also fulfill the following criteria. childhood onset: patients, who were diagnosed as growth hormone deficient during childhood, must be retested and their growth hormone deficiency confirmed before replacement therapy is started. adult onset: patients must have growth hormone deficiency as a result of hypothalamic or pituitary disease and at least one other hormone deficiency diagnosed (except for prolactin) and adequate replacement therapy instituted, before replacement therapy using growth hormone may begin. prader-willi syndrome, for improvement of body composition.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - somatropin 3.33 mg/ml - solution for injection - 5 mg/1.5ml - active: somatropin 3.33 mg/ml excipient: benzyl alcohol dibasic sodium phosphate mannitol monobasic sodium phosphate phosphoric acid poloxamer 188 sodium hydroxide water for injection - adults replacement therapy in adults with pronounced growth hormone deficiency as diagnosed in two different dynamic tests for growth hormone deficiency. patients must also fulfill the following criteria. childhood onset: patients, who were diagnosed as growth hormone deficient during childhood, must be retested and their growth hormone deficiency confirmed before replacement therapy is started. adult onset: patients must have growth hormone deficiency as a result of hypothalamic or pituitary disease and at least one other hormone deficiency diagnosed (except for prolactin) and adequate replacement therapy instituted, before replacement therapy using growth hormone may begin. prader-willi syndrome, for improvement of body composition.

Marekani - Kiingereza - NLM (National Library of Medicine)

orchid healthcare (a division of orchid chemicals & pharmaceuticals ltd.) - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 37.5 mg - venlafaxine hydrochloride extended-release capsules is indicated for the treatment of major depressive disorder. the efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8- and 12-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii-r or dsm-iv category of major depressive disorder (see clinical trials ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessne

Marekani - Kiingereza - NLM (National Library of Medicine)

homeolab usa inc. - passiflora incarnata top (unii: clf5yfs11o) (passiflora incarnata flowering top - unii:clf5yfs11o), valerian (unii: jwf5yaw3qw) (valerian - unii:jwf5yaw3qw), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), cupric acetate (unii: 39m11xph03) (cupric cation - unii:8cbv67279l), hyoscyamus niger whole (unii: 34412pdt5e) (hyoscyamus niger whole - unii:34412pdt5e) - passiflora incarnata top 2 [hp_x] - relieves restlessness, nervousness and anxiety associated with insomnia this is a natural homeopathic remedy that relieves restlessness, nervousness and anxiety associated with insomnia.

Marekani - Kiingereza - NLM (National Library of Medicine)

homeolab usa inc. - passiflora incarnata top (unii: clf5yfs11o) (passiflora incarnata flowering top - unii:clf5yfs11o), valerian (unii: jwf5yaw3qw) (valerian - unii:jwf5yaw3qw), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), cupric acetate (unii: 39m11xph03) (cupric cation - unii:8cbv67279l), hyoscyamus niger whole (unii: 34412pdt5e) (hyoscyamus niger whole - unii:34412pdt5e) - passiflora incarnata top 2 [hp_x] in 30 ml - relieves restlessness, nervousness and anxiety associated with insomnia this is a natural homeopathic remedy that relieves restlessness, nervousness and anxiety associated with insomnia.

Marekani - Kiingereza - NLM (National Library of Medicine)

healing natural oils llc - celery seed (unii: 1g1eaa320l) (celery seed - unii:1g1eaa320l), sage (unii: 065c5d077j) (sage - unii:065c5d077j) - celery seed 6 [hp_c] in 11 ml - for the temporary relief of insomnia and sleeplessness.

Marekani - Kiingereza - NLM (National Library of Medicine)

natural creations, inc. - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), arabica coffee bean (unii: 3sw678mx72) (arabica coffee bean - unii:3sw678mx72), potassium carbonate (unii: bqn1b9b9ha) (carbonate ion - unii:7ujq5ope7d), magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), passiflora incarnata top (unii: clf5yfs11o) (passiflora incarnata top - unii:clf5yfs11o), sepia officinalis j - arsenic cation (3+) 30 [hp_x] in 1 ml - uses: temporarily relieves sleeplessness due to anxiousness, excitement, exhaustion, nervousness, dreams, &/or other symptoms related to insomnia. other information: tamper seal: "sealed for your protection." do not use if seal is broken or missing. uses: temporarily relieves sleeplessness due to anxiousness, excitement, exhaustion, nervousness, dreams, &/or other symptoms related to insomnia.